Estimated reading time 5 minutes, 1 seconds.
Textron Aviation has announced the delivery of the 100th Beechcraft King Air 360 turboprop to Comprehensive Blood and Cancer Center (CBCC), a longtime Textron Aviation customer.
The Beechcraft King Air 360/360ER is designed and manufactured by Textron Aviation Inc., a Textron Inc. company.
“We take pride in providing aircraft solutions for our customers with the latest in aviation technology. The King Air 360’s updated airframe, avionics and interior provide our passengers with a comfortable and reliable flight experience,” said Lannie O’Bannion, senior vice-president of global sales and flight operations.
“The King Air family of aircraft is renowned for its versatility and reliability, and this 100th delivery of the 360 is an exciting milestone in the continued success of a legendary product.”
CBCC is a pioneer in global cancer care including cutting edge cancer clinical trials that have led to new drug developments in cancer care. Working for decades with the UCLA TRIO Network, CBCC has provided patients with access to new clinical trials. Many of these clinical trials have changed the way cancer therapy is delivered today. The CBCC CRO (Clinical Research Organization) also provides patients access to clinical trials across the world.
“The addition of this aircraft will be a game changer for us in terms of productivity,” said Dr. Ravi Patel, medical director at CBCC. “We are excited about the increased capability the King Air 360 will give us to globally expand our cancer care delivery and research”
Nearly 7,800 Beechcraft King Air turboprops have been delivered to customers around the world since 1964, making it the world’s best-selling business turboprop family. The worldwide fleet has surpassed 62 million flight hours in its 59 years, serving roles in all branches of the U.S. military and flying both commercial and special mission roles around the world.
This press release was prepared and distributed by Textron Aviation.
